Articles
-
1 week ago |
insights.citeline.com | Malcolm Spicer
-
1 week ago |
insights.citeline.com | Malcolm Spicer
Roar Of Eargo-hearX Merger Echoes Through US OTC Hearing Aid MarketThe firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment. Lilly plans to raise awareness of alopecia areata • Source: Shutterstock
-
2 weeks ago |
insights.citeline.com | Malcolm Spicer
US Consumer Health Industry Buckles Up For Another Ride As Trump Swings Tariff Tool AgainManufacturers, marketers and other businesses in the industry may be thinking, “Well, this is different” because the president ordered tariffs on a list of countries rather than on his sole first-term target of China.
-
1 month ago |
insights.citeline.com | Malcolm Spicer
Traceability Rule Compliance Extended For Providers Of Herbals, Other Food Ingredients FDA says “extension affords covered entities the additional time necessary to ensure complete coordination across the supply chain in order to fully implement the final rule’s requirements—ultimately providing FDA and consumers with greater transparency and food safety.”
-
1 month ago |
insights.citeline.com | Malcolm Spicer
ChromaDex Changing Name To Niagen Bioscience While Shifting Focus To Rx NAD+A week after announcing 2024 full-year and fourth-quarter results, the firm says its corporate name will be Niagen Bioscience Inc. starting 19 March. It stated in its latest results that during 2024 it launched Niagen Plus line of pharmaceutical-grade Niagen. ChromaDex rolled out Rx nicotinamide adenine dinucleotide products in August, along with a test kit for providers and consumers. (Source: CHromaDex)
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 18
- Tweets
- 271
- DMs Open
- No
Keep Big Picture In Focus, Have Clarity On Specifics Responding To GMP Violations Avoid “absolute chaos,” last-minute changes and over-reaction responding to FDA form 483s listing GMP violations frim inspections, says Teresa Gorecki, practice director at Compliance Architects.
RT @staceyabrams: Georgia is 1st in maternal mortality, 6th highest in infant mortality, and one of 12 states that refuse to expand Medicai…
RT @staceyabrams: Brian Kemp’s refusal to testify shows that he will do anything to win an election. Kemp wants credit for “standing up” to…